Inspired by one of the most iconic pocket knife styles of all time, this budget-friendly folder gets a minty-fresh redux.

Just in time for St. Patrick's Day, tapping into the industry’s latest trend works like a lucky charm for this award-winning ...

HelloFresh is offering new subscribers a free Zwilling Four Star 8-Inch Chef's Knife and 50% off their first delivery. The meal kit service provides pre-portioned ingredients and recipes with over 100 ...

Editor’s Note: March 6, 2026: We added two new knives for this update: the full-size Benchmade Bugout 535—an ultralight knife of exceptional quality; and the CRKT Twist Tighe, an excellent choice for ...

Rolling knife sharpeners have gained a lot of popularity in the last several years because they make sharpening incredibly easy. There are plenty of companies producing their own take on these ...

Benchmade's Osborne pocket knife is wildly popular amongst knife nerds for its distinct design and utility. The reverse tanto blade doubles as a pry bar and the the axis frame lock ensures it stays in ...

Grail stock headed for its largest single-day percentage decrease on record after the biotechnology company posted disappointing results for a trial evaluating its cancer detection tool.

The Pokemon TCG Pocket meta just got a serious shake-up with the arrival of Paldean Wonders, a brand-new set spotlighting Paldea’s most iconic creatures and trainers from the Scarlet & Violet games.

I discussed the game-changing event on Friday. Simply put, the company's trial of its Galleri multi-cancer early detection (MCED) with England's National Health Service (NHS) failed to meet its ...

The trial was designed to demonstrate a statistically significant reduction in Stage III and Stage IV disease, but the primary endpoint wasn't met. It's possible that the follow-up data will prove ...

CNBC's Jim Cramer explains why he is keeping an eye on shares of Grail and Coreweave. Got a confidential news tip? We want to hear from you. Sign up for free newsletters and get more CNBC delivered to ...

Feb 20 (Reuters) - Grail's (GRAL.O), opens new tab shares plunged nearly 50% on Friday after the company said routine screening with its cancer blood test failed to significantly boost early detection ...